Literature DB >> 19131451

Novel site-specific mast cell subpopulations in the human lung.

C K Andersson1, M Mori, L Bjermer, C-G Löfdahl, J S Erjefält.   

Abstract

BACKGROUND: Lung mast cells are stereotypically divided into connective tissue (MC(TC)) and mucosal (MC(T)) mast cells. This study tests the hypothesis that each of these subtypes can be divided further into site-specific populations created by the microenvironment within each anatomical lung compartment.
METHODS: Surgical resections and bronchial and transbronchial biopsies from non-smoking individuals were obtained to study mast cells under non-inflamed conditions. Morphometric and molecular characteristics of mast cell populations were investigated in multiple lung structures by immunohistochemistry and electron microscopy.
RESULTS: MC(T) and MC(TC) coexisted in all compartments, with MC(T) being the prevailing type in bronchi, bronchioles and the alveolar parenchyma and MC(TC) being more abundant in pulmonary vessels and the pleura. Each of the MC(TC) and MC(T) phenotypes could be further differentiated into site-specific populations. MC(TC) were significantly larger in pulmonary vessels than in small airway walls, while the reverse was observed for MC(T). Within each MC(TC) and MC(T) population there were also distinct site-specific expression patterns of the IgE receptor, interleukin-9 receptor, renin, histidine decarboxylase, vascular endothelial growth factor, fibroblast growth factor, 5-lipoxygenase and leukotriene C4 synthase (eg, bronchial MC(T) consistently expressed more histidine decarboxylase than alveolar MC(T)). Renin content was high in vascular MC(TC) but markedly lower in MC(TC) in other compartments. For both MC(TC) and MC(T), the IgE receptor was highly expressed in conducting airways but virtually absent in alveolar parenchyma.
CONCLUSIONS: These findings demonstrate novel site-specific subpopulations of lung MC(TC) and MC(T) at baseline conditions. This observation may have important implications in the future exploration of mast cells in a number of pulmonary diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131451     DOI: 10.1136/thx.2008.101683

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  41 in total

1.  Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.

Authors:  Ryan H Dougherty; Sukhvinder S Sidhu; Kavita Raman; Margaret Solon; Owen D Solberg; George H Caughey; Prescott G Woodruff; John V Fahy
Journal:  J Allergy Clin Immunol       Date:  2010-05       Impact factor: 10.793

2.  Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33.

Authors:  Ying Lai; William A Altemeier; John Vandree; Adrian M Piliponsky; Brian Johnson; Cara L Appel; Charles W Frevert; Dallas M Hyde; Steven F Ziegler; Dirk E Smith; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  J Allergy Clin Immunol       Date:  2013-11-09       Impact factor: 10.793

Review 3.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

Review 4.  Structure and composition of pulmonary arteries, capillaries, and veins.

Authors:  Mary I Townsley
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

5.  Renin released from mast cells activated by circulating MCP-1 initiates the microvascular phase of the systemic inflammation of alveolar hypoxia.

Authors:  Jie Chao; Gustavo Blanco; John G Wood; Norberto C Gonzalez
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

6.  Lin- CD34hi CD117int/hi FcεRI+ cells in human blood constitute a rare population of mast cell progenitors.

Authors:  Joakim S Dahlin; Andrei Malinovschi; Helena Öhrvik; Martin Sandelin; Christer Janson; Kjell Alving; Jenny Hallgren
Journal:  Blood       Date:  2015-12-01       Impact factor: 22.113

Review 7.  Mast cells in airway diseases and interstitial lung disease.

Authors:  Glenn Cruse; Peter Bradding
Journal:  Eur J Pharmacol       Date:  2015-05-08       Impact factor: 4.432

Review 8.  Skin microbiome and mast cells.

Authors:  Satomi Igawa; Anna Di Nardo
Journal:  Transl Res       Date:  2017-03-23       Impact factor: 7.012

9.  Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations.

Authors:  Susanna L Lundström; Rohit Saluja; Mikael Adner; Jesper Z Haeggström; Gunnar Nilsson; Craig E Wheelock
Journal:  J Lipid Res       Date:  2012-10-03       Impact factor: 5.922

10.  Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation.

Authors:  Daniel F Dwyer; Jose Ordovas-Montanes; Samuel J Allon; Kathleen M Buchheit; Marko Vukovic; Tahereh Derakhshan; Chunli Feng; Juying Lai; Travis K Hughes; Sarah K Nyquist; Matthew P Giannetti; Bonnie Berger; Neil Bhattacharyya; Rachel E Roditi; Howard R Katz; Martijn C Nawijn; Marijn Berg; Maarten van den Berge; Tanya M Laidlaw; Alex K Shalek; Nora A Barrett; Joshua A Boyce
Journal:  Sci Immunol       Date:  2021-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.